Search

In an ideal, imagined world, you would not be meeting the 14 emerging leaders in healthcare we selected in these pages but in person. You could talk to Courtney Bragg, [...]

On June 20, 2024, FDA announced that it had expanded its approval of delandistrogene moxeparvovec-rokl (Elevidys), a gene therapy for the treatment of Duchenne muscular dystrophy (DMD), to cover both [...]

The American Urological Association (AUA) recently held its 2024 annual meeting in San Antonio, Texas. As usual, the Urology Times team was onsite, delivering video and written coverage; a portion [...]

Despite the bio/pharma industry's stringent regulations and general tendency to adopt newer technologies more slowly than other industries, automated processes and robotics are increasingly commonplace in manufacturing facilities. Although initially [...]

Despite the bio/pharma industry's stringent regulations and general tendency to adopt newer technologies more slowly than other industries, automated processes and robotics are increasingly commonplace in manufacturing facilities. Although initially [...]

Despite the bio/pharma industry's stringent regulations and general tendency to adopt newer technologies more slowly than other industries, automated processes and robotics are increasingly commonplace in manufacturing facilities. Although initially [...]

We weren't planning on having so much coverage of glucagon-like peptide 1 (GLP-1) drugs in this issue. But no matter where it starts, every conversation about managing care these days [...]

Opioids and COVID-19 have made us all familiar with the terms epidemic and pandemic. What pharmacists and other health care providers might not be as familiar with, especially outside of [...]

Research efforts are continuing to expand in the area of biological therapies. These large-molecule drugs are proving to be significant revenue drivers for bio/pharma companies and are providing therapeutic options [...]

For many members of your community, the pharmacy is the first stop when a new health care issue arises. Pharmacists have seen--and helped patients manage--it all, from respiratory viruses to [...]

It is always a treat to review the results of Managed Healthcare Executives annual pharmacy survey and this year is no exception. CMS drug price negotiation under the Inflation Reduction [...]

Research efforts are continuing to expand in the area of biological therapies. These large-molecule drugs are proving to be significant revenue drivers for bio/pharma companies and are providing therapeutic options [...]

Surgical complications take a considerable toll on patients and their loved ones. But they also affect the surgeons themselves. This is the subject of a poignant article in this issue [...]

Experts believe it is likely cancer cells are more common in the body than previously thought, but typically caught early and removed in the body's cancer-immune cycle. When the system [...]

Last year the Pew Research Center announced that it was tightening up how it would conduct and report on generational research. It's crucial to account for age when comparing generations, [...]

In this issue of Urology Times, Co-Editor in Chief Gopal H. Badlani, MD, offers a thoughtful and succinct editorial on the complicated issue of disposable vs reusable cystoscopes. 'The quality [...]

There is a mental health crisis in the United States. With too few providers available for the number of individuals seeking counseling and treatment, pharmacists may be able to step [...]

Novo Holdings' acquisition of Catalent, in retrospect, was entirely logical (1). We are tempted to see echoes of Thermo Fisher's buyout of Patheon, or Lonza's swallowing of capsule maker Capsugel. [...]

The pharmacy benefit management (PBM) industry has emerged as one of the most important, interesting and perhaps controversial sectors of American healthcare. As we discuss in this issue's cover story, [...]

Since the 18th century, women have been making their mark on the pharmacy profession. History has immortalized Elizabeth Gooking Greenleaf as the first woman pharmacist: During Colonial times, Greenleaf was [...]

It has been fantastic following all the innovations being done in the non-muscle-invasive bladder cancer (NMIBC) space. In this issue, Urology Times Co-Editor in Chief Michael S. Cookson, MD, MMHC, [...]

Ozempic, once a drug that only diabetes specialists and perhaps people with the disease were aware of, has become a household word. Since last year, it has been all over [...]

Given its positioning at each new year's commencement, the J.P. Morgan Healthcare conference helps establish the tone with which the pharmaceutical industry is viewed. It is rare for major new [...]

The question of when to retire from one's profession rarely comes with an easy answer. This is especially true in medicine, where age-related physical and/or cognitive decline can result in [...]

In June 2023, FDA Commissioner Robert Califf ascribed most drug shortages to 'generic-drug companies going out of business, either because they fail to invest in quality operations or because they [...]

Making predictions at the beginning of the year is really kind of a fool's errand. Sure, it is cognitively comforting to think that events are going to unfold in a [...]

Seasonal respiratory illnesses can occur year-round. As you hold this issue of Drug Topics in your hands, we are in the midst of flu season, with seasonal flu activity elevated [...]

The past year marked significant milestones for Urology Times' Editors in Chief, Gopal H. Badlani, MD, and Michael S. Cookson, MD, MMHC, FACS. In February, Badlani was named the 2023 [...]

Pharmaceuticals are entering a transition into a far more complex era of patient therapies, and patient segmentation. It will not be an easy process. It's an evolution long in the [...]

Our last issue of 2023 features our annual State of Industry survey, which gives us a peek into what you, our readers, are thinking about U.S. healthcare. Of course, surveys [...]

Pharmaceuticals are entering a transition into a far more complex era of patient therapies, and patient segmentation. It will not be an easy process. It's an evolution long in the [...]

LUGPA celebrated its 15th anniversary this year, and Urology Times was in attendance in Lake Buena Vista, Florida, for full print and video coverage. The program was chock-full of clinical [...]

As of mid-October 2023, there were 9342 clinical trial studies targeting COVID-19 (1). This is alongside 12,086 patents that relate to COVID-19 (2). Messenger RNA (mRNA) clinical trials, however, stand [...]

The full gamut of what Managed Healthcare Executive covers is on display in this issue. In our standing 'Drugs in the Pipeline' feature we keep tabs on new drugs in [...]

As of mid-October 2023, there were 9342 clinical trial studies targeting COVID-19 (1). This is alongside 12,086 patents that relate to COVID-19 (2). Messenger RNA (mRNA) clinical trials, however, stand [...]

Happy holidays from the Drug Topics family! This time of year is best spent amongst those we love and appreciate--and there is no one we appreciate more than you, our [...]

A recent Urology Times Q&A interview addressed the topic of improving clinical efficiency. (1) With increasing demands on clinicians' time, ways to maximize and save that time are more important [...]

A July 2022 Pharmaceutical Technology[R] article (1) outlined that new therapeutics and breakthroughs in neurosciences have lagged far behind oncology or infectious diseases. In Alzheimer's disease, despite knowing for decades [...]

We are devoting 10 pages of this issue to our coverage of the 2023 PBMI Annual National Conference. Managed Healthcare Executive is the official publication of the meeting, and the [...]

A July 2022 Pharmaceutical Technology[R] article (1) outlined that new therapeutics and breakthroughs in neurosciences have lagged far behind oncology or infectious diseases. In Alzheimer's disease, despite knowing for decades [...]